Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders

Xunhua Li, Tonglin Hu, Qi Liu, Jingjie Dong, Junfeng Guo, Yaonan Hong, Yingying Shen, Yiping Shen, Jianping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2023) 142 (Supplement 1): 4035.

https://doi.org/10.1182/blood-2023-186675

Published: 2023

Journal Articles

Whole-Exome Sequencing Identifies Fanc Heterozygous Germline Mutation As an Adverse Factor for Immunosuppressive Therapy in Chinese Aplastic Anemia Patients Aged 40 or Younger: A Single-Center Retrospective Study

Yingying Shen, Qi Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Hangchao Li, Yuzhu Li, Ying Chen, Shan Liu, Qinghong Yu, Haifeng Zhuang, Zhiping Hu, Shu Deng, Jianping Shen, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2022) 140 (Supplement 1): 2432–2433.

https://doi.org/10.1182/blood-2022-164573

Published: 2022

Journal Articles

Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study

Yilei Hong, Yingying Shen, Qi Liu, Jingjie Dong, Jingjing Xiang, Wenbin Liu, Yiping Shen, Liqiang Wu, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2022) 140 (Supplement 1): 8386–8387.

https://doi.org/10.1182/blood-2022-159032

Published: 2022

Journal Articles

Apolipoprotein-a Is a Potential Prognosis Biomarker for Severe Aplastic Anemia Patients Treated with ATG-Based Immunosuppressive Therapy: A Single-Center Retrospective Study

Qi Liu, Huijie Dong, Yingying Shen, Yuzhu Li, Yilei Hong, Ying Chen, Shan Liu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Shengyun Lin, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2022) 140 (Supplement 1): 11043–11044.

https://doi.org/10.1182/blood-2022-158733

Published: 2022

Journal Articles

Efficiency and Safety of Eltrombopag for Multi-Line Failed Chinese Patients with Immune Thrombocytopenia: Cases with Decreased Megakaryocyte Response Well from Single Center Experience

Qi Liu, Yingying Shen, Yuzhu Li, Huijing Hu, Wenbin Liu, Yuechao Zhao, Huijie Dong, Yiping Shen, Yuhong Zhou, Baodong Ye, Dijiong Wu

Blood (2021) 138 (Supplement 1): 2082.

https://doi.org/10.1182/blood-2021-149374

Published: 2021

Journal Articles

Eltrombopag As Initial Monotherapy for Transfusion Dependent Patients with Low to Intermediate Risk-1 Myelodysplastic Syndrome: Single Center Experience

Yingying Shen, Hangchao Li, Jingjing Xiang, Ni Zhu, Yuzhu Li, Qi Liu, Huijie Dong, Bo Wang, Baodong Ye, Shengyun Lin, Yiping Shen, Dijiong Wu

Blood (2021) 138 (Supplement 1): 4672.

https://doi.org/10.1182/blood-2021-150600

Published: 2021

Journal Articles

Clinical Efficacy of Therapies for Transfusion-Dependent Non-Severe Aplastic Anemia: A Retrospective Cohort Study in Multiple Hospitals

Shengyun Lin, Prof.Dr., Yan Yang, Hua Yin, Chang Huang, Jian Chen, Liqiang Wu, Jianping Shen, Baodong Ye, Zhiping Hu, Yiping Shen, Zhiyin Zheng, Wenyi Shen, MD, Xingyu Lu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5111.

https://doi.org/10.1182/blood-2018-99-118727

Published: 2018

Journal Articles

Establishment of a Mouse Model of Aplastic Anemia Complicated By Iron Overload

Dijiong Wu, M.M., Xiaowen Wen, M.M., Baodong Ye, MD PhD, Wenbin Liu, M.M., Yanting Gao, M.M., Yiping Shen, BA, Yuhong Zhou, M.M., Jie Jin, MD PhD

Blood (2015) 126 (23): 4555.

https://doi.org/10.1182/blood.V126.23.4555.4555

Published: 2015

Journal Articles

Clinical Observation of Combination Therapy of Anti-Thymocyte Globulin Cyclosporine A, Hemopoietic Growth Factor and Androgen for 47 Severe Aplastic Anaemia Cases.

JianPing Shen, YuHong Zhou, Zhiying Zheng, Junfa Chen, Shengyun Lin, YiPing Shen, ZhiPing Hu, Xiusu Luo, BaoDong Ye, LongXi Yu

Blood (2006) 108 (11): 3751.

https://doi.org/10.1182/blood.V108.11.3751.3751

Published: 2006

Journal Articles

Combination Chemotherapy Including Velcade in Patients with Refractory or Relapsed Multiple Myeloma.

YuHong Zhou, QingHong Yu, ZhiPing Hu, BaoDong Ye, YiPing Shen, JianPing Shen, LongXi Yu

Blood (2006) 108 (11): 5090.

https://doi.org/10.1182/blood.V108.11.5090.5090

Published: 2006

NARROW

Identification of Anti-HLA-C Autoantibody As Risk Factor for Primary Platelet Transfusion Refractoriness in Patients with Hematologic Disorders

Whole-Exome Sequencing Identifies Fanc Heterozygous Germline Mutation As an Adverse Factor for Immunosuppressive Therapy in Chinese Aplastic Anemia Patients Aged 40 or Younger: A Single-Center Retrospective Study

Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study

Apolipoprotein-a Is a Potential Prognosis Biomarker for Severe Aplastic Anemia Patients Treated with ATG-Based Immunosuppressive Therapy: A Single-Center Retrospective Study

Efficiency and Safety of Eltrombopag for Multi-Line Failed Chinese Patients with Immune Thrombocytopenia: Cases with Decreased Megakaryocyte Response Well from Single Center Experience

Eltrombopag As Initial Monotherapy for Transfusion Dependent Patients with Low to Intermediate Risk-1 Myelodysplastic Syndrome: Single Center Experience

Clinical Efficacy of Therapies for Transfusion-Dependent Non-Severe Aplastic Anemia: A Retrospective Cohort Study in Multiple Hospitals

Establishment of a Mouse Model of Aplastic Anemia Complicated By Iron Overload

Clinical Observation of Combination Therapy of Anti-Thymocyte Globulin Cyclosporine A, Hemopoietic Growth Factor and Androgen for 47 Severe Aplastic Anaemia Cases.

Combination Chemotherapy Including Velcade in Patients with Refractory or Relapsed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only